School of Pharmacy - News

The Research Council of Finland has granted continued funding for the GeneCellNano, UNITE and ACCC Flagships for the period 2026–2028.

44% people with chronic conditions experienced medication-related burden. It was most common among people with diabetes, heart disease, rheumatic disease or other musculoskeletal disorder.

The unique Bachelor’s and Master’s degree programmes offer new insight into planetary health, faith and wellbeing, and data engineering.

Polina Abushik, Anni Hartikainen, Soila Lemmetty, Iuliia Pilipenko, Isabell Rumrich, Atte Eskelinen and Henri Hyvönen were appointed to three-year UEF Research Fellow positions.

A study conducted by the University of Eastern Finland and Fimea found that the Finnish news media has given GLP-1 agonists used to treat obesity, such as semaglutide, a great deal of attention while many other new medicines have been ignored.

Rector Tapio Määttä has appointed the Heads and Deputy Heads of Departments and Schools of the faculties. The Head and Deputy Heads of UEF Law School was appointed by Vice Rector Jussi Pihlajamäki.

The Excellent Teaching Practitioner 2025 Awards were presented at the UEF Learning Environment Seminar on 19 August.

Automated insulin delivery pumps significantly improved quality of life and reduced diabetes-related complications.

Inhibition of the lipid kinases PIKfyve and PIP4K2C provides a potentially higher barrier to resistance than conventional therapies and could be beneficial in the treatment of diseases particularly in the case of emerging viruses.